DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Sheraton Pentagon City Hotel

2024 年 03 月 14 日 7:30 上午 - 2024 年 03 月 15 日 4:15 下午

900 South Orme Street, Arlington, VA 22204, USA

Global Labeling Conference

Join speakers from around the world sharing their labeling – Germany, Japan, Belgium, UK, Canada and more!

Session 7: eLabeling: Patient Interactions, Advanced e-Labeling Initiatives, and Public/Private Consortia Insights

Session Chair(s)

Theresa  Brunone, MLS, MS

Theresa Brunone, MLS, MS

Head-Labelling Compliance and Implementation, Global Labeling

GlaxoSmithKline, United States

Kathleen  Salazar, MA, MBA

Kathleen Salazar, MA, MBA

Head, Global Labeling Implementation

Johnson & Johnson Innovative Medicine, United States

While a key focus of e-labeling is how and when labels are converted from paper to digital, important aspects of e-labeling and its adoption go beyond the conversion itself. A key measure of value is patient benefit, including accessibility of elabeling across patient populations, interoperability across various points of care and care providers, and personalization to the individual patient. And a key enabler to driving forward e-labeling is Health Authority engagement and support. This session will address regulator interactions, early-stage developments, and global adoption patterns around e-labeling as well as patient benefits and interactions through key e-labeling initiatives.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss regulator interactions, early-stage developments, and global adoption patterns for e-labeling
  • Identify key concepts and technologies related to interoperability across care platforms and within the end-to-end labeling process
  • Describe select in-flight patient-focused e-labeling initiatives and their current status

Speaker(s)

Giovanna  Ferrari, PhD

Gravitate-Health… Unlocking the Value in Electronic Product Information (ePI) for the Patient – Taking a Global Approach

Giovanna Ferrari, PhD

Pfizer Ltd, United Kingdom

Regional Labelling Lead, Senior Director

Yuri  Quintana, PhD

Co-Creating New Ways to Communicate Medication Information to Patients

Yuri Quintana, PhD

Beth Israel Deaconess Medical Center, United States

Chief, Division of Clinical Informatics

G. Scott  Gordon, PhD

FDA SPL-on-FHIR: Opportunities for Modernization and International Harmonization of Product Information

G. Scott Gordon, PhD

FDA, United States

Senior Health Informatics Officer, OSP, CDER

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。